COVID-19 crisis accelerates Indian real estate’s giant technology leap, says GlobalData
Real estate companies have started using advanced technologies like virtual tours, artificial intelligence-enabled customer engagement, digital bookings and online payments in order to draw...
Melbourne, Sydney witnessing Australia’s property bubble: Ben McEvoy
At a time when the global economy is slipping towards Covid-induced recession, property prices in Australia have been ballooning. And this property bubble is...
‘Hot Zone’ residents urged to get tested at new sites
Residents living in Victoria’s ten restricted postcodes are urged to get tested for coronavirus this week—with new sites being setup as part of a...
Responsible Technology Australia wants to show size of Covid-19 misinformation online
Social media needs to be compelled to be transparent about the extent of its misinformation problem, particularly when it comes to false information and...
Lockdown blues
Under stage three lockdown, here’s what some Melburnians are feeling
As Melbourne and some regional areas of Victoria enter stage three of lockdown just few...
Shincheonji members of South Korea donate blood plasma
In South Korea, Shincheonji church members step up to donate blood plasma for Covid-19 research and treatment
As the rate of infections is getting higher...
Sharing in the time of coronavirus
Food and sharing have become one and the same, specially more so, during the pandemic. When Jasvinder Sidhu, founder of Let’s Feed, got a...
Expecting a Rakhi gift? Ensure you are aware of biosecurity laws
With Rakhi coming up on 3 August, the department is asking those expecting gifts and delicacies from overseas to ensure that friends and family...
In times of crisis, a toast to the spirit of perseverance
Celebrating Janmastami can bring solace to those suffering from the economic and the social turbulence caused by the Covid-19 emergency
You may ask whether in...
Where are we in the race for a Covid-19 vaccine?
Oxford scientist Andrew Pollard, whose company is the closest to a finish explains
Director of the Oxford Vaccine Group Andrew Pollard and his team are...